AGGRESSIVE VARIANT PROSTATE CARCINOMA
Clinical trials for AGGRESSIVE VARIANT PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new AGGRESSIVE VARIANT PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for AGGRESSIVE VARIANT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets hard-to-treat metastatic cancers
Disease control OngoingThis early-phase trial tests a new drug (DS3201) combined with an immunotherapy (ipilimumab) in people with advanced prostate, bladder, or kidney cancer that has spread. The goal is to find the safest dose and see if the combination can help control the cancer. About 65 adults wi…
Matched conditions: AGGRESSIVE VARIANT PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 13:58 UTC
-
New hope for tough prostate cancer: Two-Drug attack after chemo
Disease control OngoingThis study tests a two-step treatment for men with an aggressive form of prostate cancer that has spread. First, patients get chemotherapy plus an immunotherapy drug. Then, they take a maintenance pill (niraparib) either alone or with more immunotherapy. The goal is to see if thi…
Matched conditions: AGGRESSIVE VARIANT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:04 UTC